Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Stem Cell Research

Free Subscription Articles published in Oncogene Retrieve available abstracts of 57 articles: HTML format Text format

Single Articles

May 2018
1. LIAO CP, Lin TP, Li PC, Geary LA, et al
   Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
   Oncogene. 2018 May 29. pii: 10.1038/s41388-018-0325.
   PubMed     Text format     Abstract available
   
   
   
2. GRUN D, Adhikary G, Eckert RL
   NRP-1 interacts with GIPC1 and alpha6/beta4-integrins to increase YAP1/Np63alpha-dependent epidermal cancer stem cell survival.
   Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0290.
   PubMed     Text format     Abstract available
   
   
   
3. BAKER A, Wyatt D, Bocchetta M, Li J, et al
   Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
   Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0251.
   PubMed     Text format     Abstract available
   
   
   February 2018
4. MANCINI R, Noto A, Pisanu ME, De Vitis C, et al
   Metabolic features of cancer stem cells: the emerging role of lipid metabolism.
   Oncogene. 2018 Feb 15. pii: 10.1038/s41388-018-0141.
   PubMed     Text format     Abstract available
   
   
   January 2018
5. O'BRIEN KP, Khan S, Gilligan KE, Zafar H, et al
   Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379.
   Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0116.
   PubMed     Text format     Abstract available
   
   
   
6. SOLOMON H, Dinowitz N, Pateras IS, Cooks T, et al
   Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
   Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0060.
   PubMed     Text format     Abstract available
   
   
   December 2017
7. PENG F, Wang JH, Fan WJ, Meng YT, et al
   Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
   Oncogene. 2017 Dec 18. pii: onc2017407. doi: 10.1038/onc.2017.
   PubMed     Text format     Abstract available
   
   
   November 2017
8. PENG F, Wang JH, Fan WJ, Meng YT, et al
   Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
   Oncogene. 2017 Nov 6. doi: 10.1038/onc.2017.
   PubMed     Text format     Abstract available
   
   
   October 2017
9. DEBEBE A, Medina V, Chen CY, Mahajan IM, et al
   Wnt/beta-catenin activation and macrophage induction during liver cancer development following steatosis.
   Oncogene. 2017;36:6020-6029.
   PubMed     Text format     Abstract available
   
   
   
10. SIZEMORE GM, Balakrishnan S, Hammer AM, Thies KA, et al
    Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1.
    Oncogene. 2017 Oct 16. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    September 2017
11. WANG F, Wang AY, Chesnelong C, Yang Y, et al
    ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
12. KIM M, Jang K, Miller P, Picon-Ruiz M, et al
    VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
    Oncogene. 2017;36:5199-5211.
    PubMed     Text format     Abstract available
    
    
    August 2017
13. LI XX, Zhang HS, Xu YM, Zhang RJ, et al
    Knockdown of IRE1alpha inhibits colonic tumorigenesis through decreasing beta-catenin and IRE1alpha targeting suppresses colon cancer cells.
    Oncogene. 2017 Aug 21. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
14. SOMASAGARA RR, Spencer SM, Tripathi K, Clark DW, et al
    RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.
    Oncogene. 2017 Aug 14. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
15. GUERRERO PA, Tchaicha JH, Chen Z, Morales JE, et al
    Glioblastoma stem cells exploit the alphavbeta8 integrin-TGFbeta1 signaling axis to drive tumor initiation and progression.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
16. LI J, Hu SB, Wang LY, Zhang X, et al
    Autophagy-dependent generation of Axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    July 2017
17. FETTIG LM, McGinn O, Finlay-Schultz J, LaBarbera DV, et al
    Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.
    Oncogene. 2017 Jul 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    June 2017
18. TIAN R, Wang J, Yan H, Wu J, et al
    Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Oncogene. 2017 Jun 19. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
19. KIYOHARA MH, Dillard C, Tsui J, Kim SR, et al
    EMP2 is a novel therapeutic target for endometrial cancer stem cells.
    Oncogene. 2017 Jun 12. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
20. PISTORE C, Giannoni E, Colangelo T, Rizzo F, et al
    DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
21. SENGUPTA S, Nagalingam A, Muniraj N, Bonner MY, et al
    Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
22. PEREZ-ALEA M, McGrail K, Sanchez-Redondo S, Ferrer B, et al
    ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    May 2017
23. RAJA E, Komuro A, Tanabe R, Sakai S, et al
    Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    April 2017
24. SU X, Napoli M, Abbas HA, Venkatanarayan A, et al
    TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway.
    Oncogene. 2017;36:2377-2393.
    PubMed     Text format     Abstract available
    
    
    
25. NIU N, Mercado-Uribe I, Liu J
    Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells.
    Oncogene. 2017 Apr 24. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
26. HU PS, Xia QS, Wu F, Li DK, et al
    NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.
    Oncogene. 2017 Apr 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    March 2017
27. RUAN D, He J, Li CF, Lee HJ, et al
    Skp2 deficiency restricts the progression and stem cell features of castration-resistant prostate cancer by destabilizing Twist.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    February 2017
28. NATSUME A, Kato T, Kinjo S, Enomoto A, et al
    Girdin maintains the stemness of glioblastoma stem cells.
    Oncogene. 2017 Feb 20. doi: 10.1038/onc.2017.
    PubMed     Text format    
    
    
    
29. ESCOLL M, Gargini R, Cuadrado A, Anton IM, et al
    Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    January 2017
30. YANG N, Wang C, Wang Z, Zona S, et al
    FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    December 2016
31. MATEO F, Arenas EJ, Aguilar H, Serra-Musach J, et al
    Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.
    Oncogene. 2016 Dec 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
32. XIE X, Kaoud TS, Edupuganti R, Zhang T, et al
    c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
    Oncogene. 2016 Dec 12. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
33. KEYSSELT K, Kreutzmann T, Rother K, Kerner C, et al
    Different in vivo and in vitro transformation of intestinal stem cells in mismatch repair deficiency.
    Oncogene. 2016 Dec 12. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
34. KERR C, Szmacinski H, Fisher ML, Nance B, et al
    Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.
    Oncogene. 2016 Dec 12. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    November 2016
35. SAREDDY GR, Viswanadhapalli S, Surapaneni P, Suzuki T, et al
    Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
36. SHI L, Wang Y, Lu Z, Zhang H, et al
    miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
37. VAN LIDTH DE JEUDE JF, Meijer BJ, Wielenga MC, Spaan CN, et al
    Induction of endoplasmic reticulum stress by deletion of Grp78 depletes Apc mutant intestinal epithelial stem cells.
    Oncogene. 2016 Nov 7. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
38. GOYAMA S, Shrestha M, Schibler J, Rosenfeldt L, et al
    Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia.
    Oncogene. 2016 Nov 7. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    October 2016
39. SIZEMORE GM, Balakrishnan S, Hammer AM, Thies KA, et al
    Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1.
    Oncogene. 2016 Oct 31. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
40. FAN H, Cui Z, Zhang H, Mani SK, et al
    DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.
    Oncogene. 2016 Oct 31. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
41. CHICHE A, Moumen M, Romagnoli M, Petit V, et al
    p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors.
    Oncogene. 2016 Oct 24. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
42. WITT AE, Lee CW, Lee TI, Azzam DJ, et al
    Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer.
    Oncogene. 2016 Oct 3. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
43. WANG J, Zhang B, Wu H, Cai J, et al
    CD51 correlates with the TGF-beta pathway and is a functional marker for colorectal cancer stem cells.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
44. JIANG YX, Yang SW, Li PA, Luo X, et al
    The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms.
    Oncogene. 2016 Aug 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    June 2016
45. BEHNAN J, Stangeland B, Hosainey SA, Joel M, et al
    Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
46. LU J, Song G, Tang Q, Yin J, et al
    MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
47. JOLY AL, Deepti A, Seignez A, Goloudina A, et al
    The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development.
    Oncogene. 2016;35:2948.
    PubMed     Text format    
    
    
    May 2016
48. YAO R, Oyanagi J, Natsume Y, Kusama D, et al
    Suppression of intestinal tumors by targeting the mitotic spindle of intestinal stem cells.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
49. NGUYEN PH, Giraud J, Staedel C, Chambonnier L, et al
    All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    April 2016
50. BOUSQUET E, Calvayrac O, Mazieres J, Lajoie-Mazenc I, et al
    RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition.
    Oncogene. 2016;35:1760-9.
    PubMed     Text format     Abstract available
    
    
    March 2016
51. LI H, Zhao X, Yan X, Jessen WJ, et al
    Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.
    Oncogene. 2016;35:1468-74.
    PubMed     Text format     Abstract available
    
    
    
52. KIM J, Liu Y, Qiu M, Xu Y, et al
    Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells.
    Oncogene. 2016;35:1334-40.
    PubMed     Text format     Abstract available
    
    
    February 2016
53. TATSUMI N, Hojo N, Yamada O, Ogawa M, et al
    Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalities.
    Oncogene. 2016;35:1003-14.
    PubMed     Text format     Abstract available
    
    
    July 2015
54. WU YC, Tang SJ, Sun GH, Sun KH, et al
    CXCR7 mediates TGFbeta1-promoted EMT and tumor-initiating features in lung cancer.
    Oncogene. 2015 Jul 27. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available
    
    
    
55. SOTOCA AM, Prange KH, Reijnders B, Mandoli A, et al
    The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
    Oncogene. 2015 Jul 6. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available
    
    
    June 2015
56. PARK SJ, Shim JW, Park HS, Eum DY, et al
    MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B.
    Oncogene. 2015 Jun 1. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available
    
    
    May 2015
57. SAMANTA S, Sun H, Goel HL, Pursell B, et al
    IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG.
    Oncogene. 2015 May 18. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: